Browsing by Author Mitchell, P.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)Citation
2005Australian experience of a modified schedule of FOLFOX with high activity and tolerability and improved convenience in untreated metastatic colorectal cancer patients.Beale, Philip; Clarke, Stephen; Friedlander, Michael; Goldstein, David; Michael, Michael; Mitchell, P.; White, Shane; Zalcberg, John; Central Clinical School: Medicine; Concord Clinical School: ANZAC Research InstituteAustralian experience of a modified schedule of FOLFOX with high activity and tolerability and improved convenience in untreated metastatic colorectal cancer patients., British Journal of Cancer, vol.92,(5),2005,pp 832-837
2011Randomized phase 2 sequencing and pharmacokinetic study of gemcitabine and oxaliplatin in advanced non-small cell lung cancerClarke, Stephen; Abraham, R.; Broad, Adam; Burns, Ivon; Diiulio, Juliana; Galettis, Peter; Links, Matthew G.; Milner, Alvin D.; Mitchell, P.; Rosenthal, Mark; Northern Clinical School: Kolling InstituteRandomized phase 2 sequencing and pharmacokinetic study of gemcitabine and oxaliplatin in advanced non-small cell lung cancer, Asia-Pacific Journal of Clinical Oncology, vol.7, 4, 2011,pp 376-384
2005Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke.Herkes, Geoffrey; Davis, Stephen; et, al; Fitt, G; Gerraty, Richard P; Hankey, Graeme J.; Macleod, M R; Mitchell, P.; Rosen, D; Stewart-Wynne, E G; PharmacyResults of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke., Cerebrovascular Diseases, vol.20,(1),2005,pp 12-7